Abstract
SsHSP14.1, a novel sHSP from the hyper-thermophilic archaeon Sulfolobus solfataricus (S. solfataricus), is reported herein to function to protect EcoR I from heat-induced inactivation. A predicted salt bridge and hydrophobic interactions were found to be important for this function.
Keywords: Small heat shock proteins (sHSPs), SsHSP14.1, Sulfolobus solfataricus (S. solfataricus), EcoR I, salt bridge, oligomer
Protein & Peptide Letters
Title: Importance of a Potential Salt Bridge and Hydrophobic Core in the Function and Oligomerization of a Small Heat Shock Protein
Volume: 17 Issue: 6
Author(s): Zhenzhen Wen, Yonghua Wang, Xun Xu, Bo Yang, Wencheng Li and Mingquan Xie
Affiliation:
Keywords: Small heat shock proteins (sHSPs), SsHSP14.1, Sulfolobus solfataricus (S. solfataricus), EcoR I, salt bridge, oligomer
Abstract: SsHSP14.1, a novel sHSP from the hyper-thermophilic archaeon Sulfolobus solfataricus (S. solfataricus), is reported herein to function to protect EcoR I from heat-induced inactivation. A predicted salt bridge and hydrophobic interactions were found to be important for this function.
Export Options
About this article
Cite this article as:
Wen Zhenzhen, Wang Yonghua, Xu Xun, Yang Bo, Li Wencheng and Xie Mingquan, Importance of a Potential Salt Bridge and Hydrophobic Core in the Function and Oligomerization of a Small Heat Shock Protein, Protein & Peptide Letters 2010; 17 (6) . https://dx.doi.org/10.2174/092986610791190273
DOI https://dx.doi.org/10.2174/092986610791190273 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Therapy of Pericardial Diseases
Current Pharmaceutical Design Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Purine and Pyrimidine Pathways as Targets in Plasmodium falciparum
Current Topics in Medicinal Chemistry Identifying Key Regulator Genes for Tuberculosis by Differential Co- Expression Analysis of Gene Expression Profiling
Current Bioinformatics Application of Multivariate Linear and Nonlinear Calibration and Classification Methods in Drug Design
Combinatorial Chemistry & High Throughput Screening Virtual Screening Against M. tuberculosis 7,8-Diaminopelargonic Acid Synthase (MtbBioA) and In Silico Toxicity Evaluation of Top Hits
Current Enzyme Inhibition Cyclodextrin-Based Delivery Systems for Arthritic Diseases: From Development to Experimental Therapeutics
Current Pharmaceutical Design Vitamin D Supplementation in Diabetic Foot Ulcers: A Current Perspective
Current Diabetes Reviews The Impact of Proteomic Advances on Bacterial Gene Annotation
Current Proteomics Covid-19: An Update on Clinical Features, Diagnosis, and Treatment Strategies
Coronaviruses Graphical Abstracts
Letters in Drug Design & Discovery Surfactant Protein A - From Genes to Human Lung Diseases
Current Medicinal Chemistry A Technological Update of Molecular Diagnostics for Infectious Diseases
Infectious Disorders - Drug Targets In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus
Current Pharmaceutical Design Recent Complications and Issues in Tuberculosis Treatment
Recent Patents on Anti-Infective Drug Discovery Subject Index To Volume 3
Current Pharmaceutical Biotechnology 3D-QSAR, Topomer CoMFA, Docking Analysis, and ADMET Predictio n of Thioether Pleuromutilin Derivatives as Antibacterial Agents
Letters in Drug Design & Discovery Design, Synthesis and Biological Profiling of Novel Phenothiazine Derivatives as Potent Antitubercular Agents
Anti-Infective Agents Vitamin D: Evolutionary, Physiological and Health Perspectives
Current Drug Targets Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis
Current Pharmaceutical Design